1. Erwin Deutsch

   • G. Müller-Berghaus
   • K. Lechner

   Obituary Pages: 105 - 106

2. Biology and treatment of myelodysplastic syndromes — developments in the past decade

   • R. Willemze
   • W. E. Fibbe
   • J. E. Landegent

   Review Article Pages: 107 - 115

3. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis

   • H. Maschek
   • V. Kaloutsi
   • A. Georgii

   Original Article Pages: 117 - 122

4. Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia — initial results

   • A. Ganser
   • G. Heil
   • D. Hoelzer

   Original Article Pages: 123 - 125

5. Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy

   • U. Mentzel
   • H. Vogt
   • D. Hoelzer

   Original Article Pages: 127 - 129

6. Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine

   • U. Jehn
   • V. Heinemann

   Original Article Pages: 131 - 134

7. IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study

   • J. Walther
   • W. Wilmanns
   • H. H. Gerhartz

   Original Article Pages: 135 - 137

8. Dose-escalation study for the treatment of Hodgkin's disease

   • V. Diehl

   Original Article Pages: 139 - 140

9. Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications

   • M. R. Clemens
   • K. Fessele
   • M. E. Heim

   Original Article Pages: 141 - 146

10. Prevalence of HCV-RNA-positive blood donors and correlation to ELISA and RIBA status

    • M. da Silva Cardoso
    • K. Koerner
    • B. Kubanek

    Original Article Pages: 147 - 151

11. Acute agranulocytosis after prolonged high-dose usage of intravenous dipyrone — a different mechanism of dipyrone toxicity?

    • J. Sabbaga
    • C. Osawa
    • I. Cecconello

    Case Report Pages: 153 - 155

12. Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection

    • A. Gruber
    • L. Grillner
    • M. Björkholm

    Case Report Pages: 157 - 159

13. Possible selective effects of Interferon α-2b on a malignant clone in a case of polycythemia vera

    • M. Hino
    • E. Futami
    • H. Morii

    Case Report Pages: 161 - 162

14. Flow-cytometric enumeration of reticulocytes

    • D. R. van Bockstaele
    • J. O'Connor

    Letter to the Editors Pages: 163 - 163

15. The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

    • K. B. Miller
    • K. Kyungmann
    • M. J. O'Connell

    Erratum Pages: 164 - 164